RecruitingPhase 2NCT04191460

Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer

Studying Squamous cell carcinoma of head and neck

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Erasmus Medical Center
Intervention: cRGD-ZW800-1.(drug)
Enrollment: 28 enrolled
Eligibility: 18 years · All sexes
Timeline: 2022 – 2025

Study locations (1)

Erasmus University Medical Center, Rotterdam, South Holland, Netherlands

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04191460 on ClinicalTrials.gov

Other trials for Squamous cell carcinoma of head and neck

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE3NCT07333274
Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
Shandong Cancer Hospital and Institute
RECRUITINGPHASE3NCT07026474
Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC
Universität des Saarlandes
RECRUITINGPHASE1NCT07182149
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Normunity AccelCo, Inc.
RECRUITINGNANCT07203911
Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial
Tobias Todsen
RECRUITINGNANCT07180901
Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
Centre hospitalier de l'Université de Montréal (CHUM)
ACTIVE NOT RECRUITINGEARLY PHASE1NCT07435415
Local Injection Methylene Blue Combined With Radiation in HNSCC Patients
China Medical University Hospital
RECRUITINGPHASE2NCT07088211
Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
RECRUITINGPHASE2NCT07040956
A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.
West China Hospital

See all trials for Squamous cell carcinoma of head and neck →

← Back to all trials